Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1991-10-15
1993-08-10
Ivy, C. Warren
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514912, 546 80, A61K 3154, A61K 31445, C07D51312
Patent
active
052350592
ABSTRACT:
Conformationally constrained tricyclic thienothiopyran compounds are topically effective carbonic anhydrase inhibitors useful in the treatment of ocular hypertension and glaucoma associated therewith.
REFERENCES:
patent: 4619939 (1986-10-01), Maren
patent: 4677115 (1987-06-01), Baldwin et al.
patent: 4797413 (1989-01-01), Baldwin et al.
Baldwin John J.
Ponticello Gerald S.
DiPrima Joseph F.
Ivy C. Warren
Mach D. Margaret
Merck & Co. , Inc.
Nicholson William H.
LandOfFree
Tricyclic thienothiopyran carbonic anhydrase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic thienothiopyran carbonic anhydrase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic thienothiopyran carbonic anhydrase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1726412